Analysis Shows Vernakalant Hydrochloride Injection Increases Conversion to Normal Heart Rhythm in Acute Atrial Fibrillation Patients Treated Within 48 Hour... (eartpalpitations weakness shortness of b...)

HOME >> MEDICINE >> TECHNOLOGY

Analysis Shows Vernakalant Hydrochloride Injection Increases Conversion to Normal Heart Rhythm in Acute Atrial Fibrillation Patients Treated Within 48 Hours of Onset

Date:10/10/2007

eart palpitations, weakness, shortness of breath and angina (chest pain).(3)

About Astellas

Astellas Pharma US, Inc., located in Deerfield, Illinois, is a U.S. affiliate of Tokyo-based Astellas Pharma Inc. Astellas is a pharmaceutical company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products. The organization is committed to becoming a global category leader in focused areas by combining outstanding R&D and marketing capabilities. In the US, Astellas markets products in the areas of Immunology, Urology, Anti-Infectives, Cardiovascular and Dermatology. For more information about Astellas Pharma US, Inc., please visit our website at http://www.astellas.com/us.

References

(1) Arrhythmias Originating in the Atria. American Heart Association:

http://www.americanheart.org/presenter.jhtml?identifier=10. Accessed

July 10, 2007.

(2) Miyasaka Y, Barnes ME, Gersh BJ, et al. American Heart Association:

http://circ.ahajournals.org/cgi/content/abstract/114/2/119?etoc.

Accessed June 28, 2007.

(3) Mayo Clinic. Atrial fibrillation. Available at:

http://www.mayoclinic.com/health/atrial-fibrillation/DS00291. Accessed

October 26, 2006.

SOURCE Astellas Pharma US, Inc.
Copyright©2007 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3
Related medicine technology :

1. Genetic Analysis Systems Enter the Clinical Mainstream
2. Blood Gas Analysis: The Pros and Cons of Point-Of-Care Testing
3. Interim Analysis of Crinone Pregnancy Study to Be Published in American Society for Reproductive Medicine Journal
4. Arterial Plaque Significantly Reduced in Women Age 50-59 Taking Hormones, Says New Analysis of Womens Health Initiative Data
5. New Analysis of WHI Data Shows Reduced Levels of Coronary Artery Calcification, a Predictor of Cardiovascular Events, in Women aged 50-59 taking Estrogen Therapy
6. Haemacure Announces Preliminary Findings of its Plasma Discard Analysis
7. Further Statistical Analysis of the Recent Phase III trial on Lead Product M6G Shows Additional Benefits
8. Poniard Pharmaceuticals Announces Promising Data From Interim Safety Analysis of Phase 1 Combination Trials of Picoplatin in Colorectal and Prostate Cancers
9. ARRIVE Registry Analysis Identifies Predictors of Stent Thrombosis in Real-World Use of Drug-Eluting Stents
10. Cypher Sirolimus-Eluting Coronary Stent Had Similar Results to Bypass Surgery and Better Outcomes Than Bare Metal Stents in Subgroup Analysis of Diabetic Patients With Multivessel Coronary Disease
11. New Analysis of Data Shows Treatment With Abbotts Humira (Adalimumab) Significantly Reduced Disease-Related Hospitalization for Patients with Crohns Disease

Post Your Comments:

(Date:12/14/2009)... 14 Seven leading cancer ... US Oncology Research participated in ... the 2009 San Antonio Breast ... at the Henry B. Gonzalez ... Texas . Fifteen others presented ...

(Date:12/14/2009)... The board of directors of Eli Lilly and Company ... for the first quarter of 2010 of $0.49 a ... dividend is payable March 10, 2010 to shareholders of ... February 12, 2010. ,, Lilly, a leading innovation-driven corporation, ... applying the latest research from its own worldwide laboratories ...

(Date:12/14/2009)... Medical Corporation (OTC Bulletin Board: CONX), a ... kits, and BG Medicine, Inc. (BGM), a ... a supply agreement whereby Corgenix will manufacture ... assay (ELISA) microtiter format exclusively for BG ... in the United States of the BGM ...

[0] US Oncology Research Network Participates in Seven Oral Clinical Studies Presentations and 15 Posters at 2009 San Antonio Breast Cancer Symposium [0] Lilly Declares First-Quarter 2010 Dividend [0] Corgenix and BG Medicine Announce Supply Agreement for BGM Galectin-3(TM)

... for ... From Chronic Pain, ALBUQUERQUE, New Mexico, March 31 ... life,announced today that the U.S. Food and Drug Administration (FDA) ... the United,States. The patented, high-tech medical device is intended to ...

... Ranexa(R) mechanism of action -, CHICAGO, March 31 ... that ranolazine significantly (p<0.001),shortened the QT interval of patients ... which is caused by a genetic mutation in the ... problems, including,sudden death. Ranolazine also shortened cardiac relaxation time ...

Other Medicine Technology:Kingfisher Announces FDA 510(k) Clearance of Breakthrough KFH Energy for Chronic Pain Sufferers 2 Ranolazine Shortens QT Interval and Improves Cardiac Relaxation in Study of Patients With Genetic Sodium Channel Disorder 2 Ranolazine Shortens QT Interval and Improves Cardiac Relaxation in Study of Patients With Genetic Sodium Channel Disorder 3

Kingfisher Announces FDA 510(k) Clearance of Breakthrough KFH Energy for Chronic Pain Sufferers Ranolazine Shortens QT Interval and Improves Cardiac Relaxation in Study of Patients With Genetic Sodium Channel Disorder

(Date:12/15/2009)... of Spa, Massage, and Medical tables announces its partnership with ... comfort system to ease pressure felt while laying face down ... ... Pennsylvania (PRWEB) December 15, 2009 -- OAKWORKS®, Inc., the premier ... the launch of the Utopian Massage Table with patent pending ...

(Date:12/15/2009)... in the Dec. 15 issue of the Journal ... or obese increases the risk for developing obstructive sleep ... , Results indicate that the risk of ... older increased 3.5 fold with each standard-deviation increase in ... OSA did not significantly increase with increasing BMI among ...

(Date:12/14/2009)... drugs, and more… , ... Santa ... collaboration with scientists at University of Michigan, have developed synthetic ... natural red blood cells, including softness, flexibility, and the ability ... function of natural red blood cells is to carry oxygen, ...

(Date:12/14/2009)... Heska Corporation (Nasdaq: HSKA ; "Heska" ... veterinary diagnostic and specialty products, today announced ... new DRI-CHEM® 7000 Veterinary Chemistry Analyzer (the ... ,, Customers receiving these analyzers have invested ... available to the veterinary in-clinic market. ...

(Date:12/14/2009)... 14 Tough Enough To Wear Pink(TM) (TETWP), ... celebrated its fifth anniversary at the signature Tough ... National Finals Rodeo (Wrangler NFR) in Las Vegas. ... rodeo cowboys, the support of the western industry ... crowd sported pink shirts, hats, bracelets and more. ...

Breaking Medicine News(10 mins):Health News:Wellness Equipment Manufacturer Announces Revolutionary New Adjustable Breast Comfort System Available on Utopian Portable Massage Table 2 Health News:Wellness Equipment Manufacturer Announces Revolutionary New Adjustable Breast Comfort System Available on Utopian Portable Massage Table 3 Health News:Wellness Equipment Manufacturer Announces Revolutionary New Adjustable Breast Comfort System Available on Utopian Portable Massage Table 4 Health News:Obesity increases the risk for obstructive sleep apnea in adolescents, but not in younger children 2 Health News:Synthetic Red Blood Cells Developed 2 Health News:Synthetic Red Blood Cells Developed 3 Health News:Heska Announces Installation of New Chemistry Analyzer 2 Health News:Heska Announces Installation of New Chemistry Analyzer 3 Health News:Tough Enough To Wear Pink(TM) Celebrates Fifth Anniversary 2 Health News:Tough Enough To Wear Pink(TM) Celebrates Fifth Anniversary 3 Health News:Tough Enough To Wear Pink(TM) Celebrates Fifth Anniversary 4

[0] Wellness Equipment Manufacturer Announces Revolutionary New Adjustable Breast Comfort System Available on Utopian Portable Massage Table [1] Obesity increases the risk for obstructive sleep apnea in adolescents, but not in younger children [0] Synthetic Red Blood Cells Developed [0] Heska Announces Installation of New Chemistry Analyzer [0] Tough Enough To Wear Pink(TM) Celebrates Fifth Anniversary

... of NDA for Novel Antidepressant and ... Global Growth for Once-Daily Tramadol - LAVAL, QC, Nov. ... its results for the third quarter ended,September 30, 2008. All ... very pleased with the progress of our business," said James ...

... Quarter Adjusted FIFO EBITDA Increases 9.5% to $21.2 Million , ... Sales Grow by 3.7% , Gross Margin Improves to ... $22.1 Million in the Third,Quarter of 2007 , NEW YORK, ... the third quarter ended September 27, 2008., Third Quarter Key ...

... Nov. 7 Sunrise Senior Living,Inc. (NYSE: SRZ ... quarter 2008. Sunrise will host a conference call and ... "This quarter was very difficult as we incurred a ... "Our team has,been fully committed to grinding down cash ...

... 7 One Million Dollars. That,s what,Philadelphia Eagles placekicker ... But here,s the kicker: Akers needs to boot a ... record that,s stood for the past 38,years., Akers, ... leader,accepted the challenge from Beachbody, maker of the revolutionary ...

... a Family Nurse Practitioner and herbalist announces her first product, Omyst™, ... has been successfully tested on over 2,000 patients and has been ... scratches, rashes, insect bites, stings and sutures. , ... ...

... detection and treatment offer encouragement for people with cancer; Allsup ... , ... Belleville, Ill. (PRWEB) November ... offer significant encouragement for people with cancer and their families, ...

Labopharm Reports Results for Third Quarter Fiscal 2008 Duane Reade Holdings, Inc. Reports Third Quarter Results Sunrise Reports Financial Results for Third Quarter 2008 KICKING FOR A CAUSE: Beachbody Pledges $1 million if Akers Breaks NFL Longest Field Goal Nurse Practitioner Creates Healing Herbal First-aid Spray More People Living Longer After Cancer Diagnosis

... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...

... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...

... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...

... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...

Medicine Products:

Dopamine, Plasma Donath Landsteiner DNA Double Stranded Antibody, IgG DNA Content/Cell Cycle Analysis, Colon

Analysis Shows Vernakalant Hydrochloride Injection Increases Conversion to Normal Heart Rhythm in Acute Atrial Fibrillation Patients Treated Within 48 Hour...(eartpalpitations weakness shortness of b...),Health